Boothbay Fund Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-19,213
Closed -$6.27M 1853
2025
Q2
$6.27M Buy
19,213
+9,123
+90% +$2.52M 0.19% 241
2025
Q1
$2.72M Buy
+10,090
New +$2.59M 0.09% 359
2024
Q4
Sell
-2,556
Closed -$703K 1469
2024
Q3
$703K Sell
2,556
-830
-25% -$216K 0.02% 864
2024
Q2
$823K Sell
3,386
-11,630
-77% -$1.84M 0.02% 790
2024
Q1
$2.24M Buy
+15,016
New +$2.5M 0.06% 469
2023
Q4
Hold
0
1635
2022
Q4
Sell
-1,093
Closed -$219K 1977
2022
Q3
$219K Sell
1,093
-6,791
-86% -$1.3M 0.01% 1761
2022
Q2
$1.15M Buy
+7,884
New +$1.12M 0.04% 752
2022
Q1
Hold
0
2259
2021
Q4
Hold
0
1835
2021
Q3
Hold
0
1881
2021
Q2
Hold
0
1831
2021
Q1
Hold
0
1513
2020
Q4
Hold
0
1224
2020
Q3
Hold
0
1029
2020
Q2
Hold
0
951
2020
Q1
Hold
0
838
2019
Q4
Hold
0
839
2019
Q3
Hold
0
758
2019
Q2
Sell
-12,800
Closed -$982K 723
2019
Q1
$1.2M Buy
+12,800
New +$1.07M 0.16% 199
2018
Q4
Hold
0
650
2018
Q3
Hold
0
780
2018
Q2
Sell
-2,666
Closed -$264K 736
2018
Q1
$318K Sell
2,666
-666
-20% -$85.9K 0.05% 453
2017
Q4
$423K Buy
+3,332
New +$419K 0.08% 316
2017
Q3
Sell
-4,186
Closed -$357K 596
2017
Q2
$334K Buy
+4,186
New +$268K 0.09% 369

Other funds holding ALNY